Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
133
datasets available to search
ShareScore release 0.7.1
Dataset results
133 results for “Bia”
Skin Barrier Function and Inflammation in Aging: The BIA Study
ClinicalTrials.gov study NCT06750653. IPD Sharing: YES. Countries: 1. Publications: 0.
Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa
ClinicalTrials.gov study NCT02169479. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa
ClinicalTrials.gov study NCT02169453. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects
ClinicalTrials.gov study NCT02092168. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide
ClinicalTrials.gov study NCT01533116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
ClinicalTrials.gov study NCT01679002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive.
ClinicalTrials.gov study NCT02281448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics
ClinicalTrials.gov study NCT02170376. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Rasagiline on BIA 9-1067 Pharmacokinetics
ClinicalTrials.gov study NCT01532141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment
ClinicalTrials.gov study NCT02101190. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites
ClinicalTrials.gov study NCT02172755. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058
ClinicalTrials.gov study NCT03708146. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of
ClinicalTrials.gov study NCT03097211. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Bioavailability Study of BIA 5-453
ClinicalTrials.gov study NCT03090568. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Absorption, Distribution, Metabolism and Excretion of [14C] Labelled BIA 5-1058
ClinicalTrials.gov study NCT04069130. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin
ClinicalTrials.gov study NCT02779348. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202
ClinicalTrials.gov study NCT02763800. IPD Sharing: NO. Countries: 1. Publications: 0.
BIA Versus Physician Adjustment in Acute Kidney Injury Patients Requiring Renal Replacement Therapy
ClinicalTrials.gov study NCT03916861. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-202
ClinicalTrials.gov study NCT02763787. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics
ClinicalTrials.gov study NCT03094156. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.